Malta - inglês - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - diclofenac sodium - modified-release tablet - diclofenac sodium 75 mg - antiinflammatory and antirheumatic products

Malta - inglês - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - diclofenac sodium - modified-release tablet - diclofenac sodium 100 mg - antiinflammatory and antirheumatic products

Estados Unidos - inglês - NLM (National Library of Medicine)

yung shin pharmaceutical industrual co., ltd. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications [see warnings and precautions (5.2)] . diclofenac sodium and misoprostol delayed-release tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac sodium/misoprostol, other prostaglandins, or any components of the drug product [see warnings and precautions (5.7, 5.9)] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8)] - in the setting of coronary artery bypass g

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - diclofenac sodium; lactose monohydrate; misoprostol - modified-release tablet - 75/0.2 milligram(s) - acetic acid derivatives and related substances; diclofenac, combinations

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - diclofenac sodium; misoprostol - modified-release tablet - 50 mg/0.2 milligram(s) - acetic acid derivatives and related substances; diclofenac, combinations

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - diclofenac sodium; misoprostol - modified-release tablet - 75/0.2 milligram(s) - acetic acid derivatives and related substances; diclofenac, combinations

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

imbat limited - diclofenac sodium; misoprostol - modified-release tablet - 50/0.2 milligram(s) - acetic acid derivatives and related substances; diclofenac, combinations - non-steroidal anti-inflammatory - it is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

aenova ip gmbh - diclofenac sodium; omeprazole - modified-release capsule, hard - 75/20 milligram(s) - acetic acid derivatives and related substances; diclofenac, combinations

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - diclofenac sodium; misoprostol - modified-release tablet - 75/0.2 milligram(s) - acetic acid derivatives and related substances; diclofenac, combinations

Malta - inglês - Medicines Authority

pharmaswiss Česká republika s.r.o. jankovcova 1569/2c, prague 17000, czech republic - omeprazole, diclofenac sodium - modified-release hard capsule - diclofenac sodium 75 mg omeprazole 20 mg - antiinflammatory and antirheumatic products